Ek B
Acta Physiol Scand Suppl. 1985;546:1-39.
Radioligand binding studies show that both beta 1- and beta 2-adrenoceptors were present in the colon wall, but with a considerably higher concentration of the beta 2-subtype than of the beta 1-subtype. The effect of selective beta-adrenoceptor agonists on isometric force recordings of spontaneous contractile activity and electrically integrated activity were determined in isolated proximal cat and rat colon strips. The use of selective beta-adrenoceptor blocking agents revealed both beta 1- and beta 2-adrenoceptor inhibitory interaction by the beta-agonists employed. Comparison of qualitative effects of the selective beta-adrenoceptor agonists led to the hypothesis that the beta 1- and beta 2-adrenoceptors were separated on two functional levels within the colon organ. This hypothesis was confirmed by the reduced maximal inhibitory response of the partial beta-adrenoceptor agonist, prenalterol, induced by tetrodotoxin. Further confirmation was found in the decrease in affinity after tetrodotoxin treatment of the beta-adrenoceptor antagonist, metoprolol. Pretreatment with 6-hydroxy-dopamine induced an upregulation of the beta 1-adrenoceptor density but a decrease in the total efficacy of prenalterol. This may additionally indicate a beta 1-adrenoceptor-mediated effect of endogenously released noradrenaline and the requirement of sympathetic nerves for part of the beta-adrenoceptor mediated effect. Atropine and physostigmine influenced the basal contractile activity in a way suggesting that endogenous cholinergic tone existed in the isolated colon preparation. Furthermore, atropine shifted the concentration-effect curves for isoprenaline and terbutaline in a way suggesting that this tonus exerts functional antagonism for the beta-adrenoceptor stimulation. The efficacy of prenalterol was increased by atropine and was markedly reduced by extremely low concentrations of carbachol and bethanechol. This reveals that functional antagonism may be exerted at more than one effector level in the colon wall. Furthermore, it indicates that the nerves responsible for the propagation of the inhibitory effect to beta-adrenoceptor stimulation in the nervous plexa are not of the cholinergic type. It is concluded that the beta 1-adrenoceptor mediates the inhibitory sympathetic effect mainly in nervous plexa of the colon, whereas the beta 2-adrenoceptor mediates this effect at the smooth muscle cells.
放射性配体结合研究表明,β1 -和β2 -肾上腺素能受体均存在于结肠壁中,但β2亚型的浓度明显高于β1亚型。在离体的猫和大鼠近端结肠条上,测定了选择性β -肾上腺素能受体激动剂对自发收缩活动和电整合活动的等长力记录的影响。使用选择性β -肾上腺素能受体阻断剂揭示了所使用的β -激动剂对β1 -和β2 -肾上腺素能受体的抑制性相互作用。对选择性β -肾上腺素能受体激动剂的定性作用进行比较后得出假说,即β1 -和β2 -肾上腺素能受体在结肠器官内的两个功能水平上是分开的。河豚毒素诱导的部分β -肾上腺素能受体激动剂普瑞特罗的最大抑制反应降低证实了这一假说。在河豚毒素处理β -肾上腺素能受体拮抗剂美托洛尔后亲和力降低中发现了进一步的证实。用6 -羟基多巴胺预处理可诱导β1 -肾上腺素能受体密度上调,但普瑞特罗的总效能降低。这可能还表明内源性释放的去甲肾上腺素的β1 -肾上腺素能受体介导作用以及交感神经对部分β -肾上腺素能受体介导作用的需求。阿托品和毒扁豆碱以某种方式影响基础收缩活动,提示在离体结肠标本中存在内源性胆碱能张力。此外,阿托品使异丙肾上腺素和特布他林的浓度 - 效应曲线发生偏移,提示这种张力对β -肾上腺素能受体刺激发挥功能性拮抗作用。阿托品可提高普瑞特罗的效能,而极低浓度的卡巴胆碱和氨甲酰甲胆碱则可使其明显降低。这表明功能性拮抗作用可能在结肠壁的多个效应器水平上发挥作用。此外,这表明在神经丛中负责将抑制作用传递至β -肾上腺素能受体刺激的神经不是胆碱能类型。结论是,β1 -肾上腺素能受体主要在结肠的神经丛中介导抑制性交感效应,而β2 -肾上腺素能受体则在平滑肌细胞中介导此效应。